33577896/Experiment 1/Signature 1: Difference between revisions
From BugSigDB
Claregrieve1 (talk | contribs) (Created page with "{{Signature |Base page=Study 498/Experiment 1 |Source=Figure 3B |Description=Differential microbial abundance between non-COVID controls and COVID-19 infected patients |Abunda...") |
m (WikiWorks moved page SARS-CoV-2 infection and viral load are associated with the upper respiratory tract microbiome/Experiment 1/Signature 1 to SARS-CoV-2 infection and viral load are associated with the upper respiratory tract microbiome/Experiment 1/Signature 1: PMID as study pagename) |
||
(2 intermediate revisions by one other user not shown) | |||
Line 2: | Line 2: | ||
|Base page=Study 498/Experiment 1 | |Base page=Study 498/Experiment 1 | ||
|Source=Figure 3B | |Source=Figure 3B | ||
|Description= | |Description=Differences in the abundance of taxa of the URT microbiome between adults with and without SARS�CoV-2 infection. Differential abundance testing was conducted using DESeq2 models at the ASV level | ||
including age and sex as covariates B, Bar plot depicting the log2 FCs and SEs for ASVs that were significantly | |||
different between groups. | |||
|Abundance in Group 1=increased | |Abundance in Group 1=increased | ||
|NCBI=1871086, 156978, 1720, 2049028 | |NCBI=1872515, 1871086, 76517, 156978, 1720, 1582879, 2049028, 33031, 1971214, 821, 165179, 258, 76517 | ||
|State=Complete | |State=Complete | ||
}} | }} |
Latest revision as of 20:12, 17 February 2025
Reviewed Marked as Reviewed by Peace Sandy on 2024-1-15
Curated date: 2021/07/10
Curator: Claregrieve1
Revision editor(s): Claregrieve1, Peace Sandy, WikiWorks
Source: Figure 3B
Description: Differences in the abundance of taxa of the URT microbiome between adults with and without SARS�CoV-2 infection. Differential abundance testing was conducted using DESeq2 models at the ASV level including age and sex as covariates B, Bar plot depicting the log2 FCs and SEs for ASVs that were significantly different between groups.
Abundance in Group 1: increased abundance in Symptomatic, mild to moderate COVID-19 patients
Revision editor(s): Claregrieve1, Peace Sandy, WikiWorks